Literature DB >> 29140108

Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.

Aaron Christensen-Quick1, Christophe Vanpouille2, Andrea Lisco3, Sara Gianella1.   

Abstract

The inherent stability of a small population of T cells that are latently infected with HIV despite antiretroviral therapy (ART) remains a stubborn obstacle to an HIV cure. By exploiting the memory compartment of our immune system, HIV maintains persistence in a small subset of quiescent cells with varying phenotypes, thus evading immune surveillance and clinical detection. Understanding the molecular and immunological mechanisms that maintain the latent reservoir will be critical to the success of HIV eradication strategies. Human cytomegalovirus (CMV), another chronic viral infection, frequently co-occurs with HIV and occupies an oversized proportion of memory T cell responses. CMV and HIV have both evolved complex strategies to manipulate our immune system for their own advantage. Given the increasingly clear links between CMV replication, chronic immune activation, and increased HIV reservoirs, we present a closer examination of the interplay between these two chronic coinfections. Here we review the effects of CMV on the immune system and show how they may affect persistence of the latent HIV reservoir during ART. The studies described herein suggest that hijacking of cytokine and chemokine signaling, manipulation of cell development pathways, and transactivation of HIV expression by CMV might be pouring gas on the fire of HIV persistence. Future interventional studies are required to formally determine the extent to which CMV is causally associated with inflammation and HIV reservoir expansion.

Entities:  

Keywords:  CMV; HIV; inflammation; persistence; reservoir

Mesh:

Substances:

Year:  2017        PMID: 29140108      PMCID: PMC5684659          DOI: 10.1089/aid.2017.0145

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  85 in total

1.  CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.

Authors:  M A Suni; S A Ghanekar; D W Houck; H T Maecker; S B Wormsley; L J Picker; R B Moss; V C Maino
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

2.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery.

Authors:  Shaobo Han; Ayuna Asoyan; Hannah Rabenstein; Naoko Nakano; Reinhard Obst
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

3.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency.

Authors:  Michael Schmueck-Henneresse; Radwa Sharaf; Katrin Vogt; Benjamin J D Weist; Sybille Landwehr-Kenzel; Henrike Fuehrer; Anke Jurisch; Nina Babel; Cliona M Rooney; Petra Reinke; Hans-Dieter Volk
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

5.  Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA.

Authors:  Sara Gianella; Christy M Anderson; Milenka V Vargas; Douglas D Richman; Susan J Little; Sheldon R Morris; Davey M Smith
Journal:  J Infect Dis       Date:  2012-12-28       Impact factor: 5.226

6.  Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.

Authors:  Sara Gianella; Antoine Chaillon; Ece A Mutlu; Phillip A Engen; Robin M Voigt; Ali Keshavarzian; John Losurdo; Prachi Chakradeo; Steven M Lada; Masato Nakazawa; Alan L Landay
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

Review 7.  Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.

Authors:  D C Johnson; N R Hegde
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

8.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

Review 9.  Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation.

Authors:  Brian P McSharry; Selmir Avdic; Barry Slobedman
Journal:  Viruses       Date:  2012-10-25       Impact factor: 5.048

10.  In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.

Authors:  Riddhima Banga; Francesco Andrea Procopio; Matthias Cavassini; Matthieu Perreau
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more
  27 in total

1.  Dissecting the Role of DDX21 in Regulating Human Cytomegalovirus Replication.

Authors:  Hongyun Hao; Tian Han; Baoqin Xuan; Yamei Sun; Shubing Tang; Nan Yue; Zhikang Qian
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

2.  Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed Viremia.

Authors:  Aurelie Gouel-Cheron; Martha Nason; Adam Rupert; Virginia Sheikh; Greg Robby; Gary A Fahle; Irini Sereti
Journal:  Open Forum Infect Dis       Date:  2020-01-11       Impact factor: 3.835

Review 3.  HIV infection and coronary heart disease: mechanisms and management.

Authors:  Priscilla Y Hsue; David D Waters
Journal:  Nat Rev Cardiol       Date:  2019-06-10       Impact factor: 32.419

Review 4.  Role of Noncommunicable Diseases (NCDs) in Resource-Limited Settings (RLS).

Authors:  Mosepele Mosepele; Elizabeth Botsile
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

5.  Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.

Authors:  Aaron Christensen-Quick; Marta Massanella; Andrew Frick; Stephen A Rawlings; Celsa Spina; Milenka Vargas-Meneses; Rachel Schrier; Masato Nakazawa; Christy Anderson; Sara Gianella
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

Review 6.  Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era.

Authors:  Adam W Carrico; Emily M Cherenack; Leah H Rubin; Roger McIntosh; Delaram Ghanooni; Jennifer V Chavez; Nichole R Klatt; Robert H Paul
Journal:  Psychosom Med       Date:  2022-08-28       Impact factor: 3.864

7.  Subclinical Cytomegalovirus and Epstein-Barr Virus Shedding Is Associated with Increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.

Authors:  Antoine Chaillon; Masato Nakazawa; Stephen A Rawlings; Genevieve Curtin; Gemma Caballero; Brianna Scott; Christy Anderson; Sara Gianella
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

Review 8.  Clinical consequences of asymptomatic cytomegalovirus in treated human immunodeficency virus infection.

Authors:  Samuel R Schnittman; Peter W Hunt
Journal:  Curr Opin HIV AIDS       Date:  2021-05-01       Impact factor: 4.283

Review 9.  Overview of Human Cytomegalovirus Pathogenesis.

Authors:  Heather L Fulkerson; Maciej T Nogalski; Donna Collins-McMillen; Andrew D Yurochko
Journal:  Methods Mol Biol       Date:  2021

10.  Anti-cytomegalovirus Immunoglobulin G Is Linked to CD4 T-cell Count Decay in Human Immunodeficiency Virus (HIV) Elite Controllers.

Authors:  Stephane Isnard; Rayoun Ramendra; John Lin; Sanket Kant; Brandon Fombuena; Jing Ouyang; Xiaorong Peng; Mohamed El Far; Cécile Tremblay; Nicole F Bernard; Jean-Pierre Routy
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.